{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:24:44Z","timestamp":1790375084262,"version":"4.1.0"},"reference-count":33,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"unspecified","delay-in-days":33,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021096","name":"George Institute for Global Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2025,1,13]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Women in the Philippines experience significant health and economic burdens of breast cancer. The Philippines has reformed financial protection for breast cancer but does not have a national early detection and treatment programme. This study aims to model the health and economic impacts of ACT NOW (a pilot breast cancer programme that navigates women through free early detection to treatment) through an extended cost-effectiveness analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A microsimulation decision tree model was used to model the ACT NOW intervention (including annual clinical breast examination (CBE) and biannual breast ultrasound for women at high risk of breast cancer) over 5 years for healthy women 40\u201369 years old. Outcomes included health gains (breast cancer deaths saved), financial protection (financial catastrophes saved) and incremental cost-effectiveness ratios (ICER) (cost per disability-adjusted life year (DALY) saved). Outcomes were stratified by income group. Probabilistic, one-way sensitivity and scenario analyses explored uncertainty.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Over 5 years, the ACT NOW intervention is cost-effective with an ICER of PHP60 711 (USD1098) (average incremental cost PHP743 [95% UI 424\u2013960] and DALYs saved 0.01 [95% UI 0.01\u20130.02], below Philippines 2022 gross domestic product per capita PHP178 751). Per 100\u2009000\u2009women, 57 deaths and eight financial catastrophes were saved. Cost-effectiveness did not vary significantly by income, but higher income groups incurred greater costs and lower DALYs. Results were sensitive to proportion of late-stage breast cancers post intervention, treatment adherence, intervention costs and downstaging effectiveness. Trade-offs are apparent between government contributions to financial protection and rates of financial catastrophe.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Early detection interventions (annual CBE, biannual breast ultrasound if at high risk of breast cancer) are likely to be cost-effective, reduce breast cancer-related mortality through detection at earlier stages and modestly effective in reducing the incidence of financial catastrophe. Further research is required to establish the best implementation model to pursue full implementation and ways of designing equity-based screening interventions.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgh-2024-016402","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T16:05:13Z","timestamp":1738598713000},"page":"e016402","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Modelling the health, financial protection and equity impacts of upscaling the ACT NOW early intervention breast cancer pilot program in the Philippines: an extended cost-effectiveness analysis"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8379-371X","authenticated-orcid":false,"given":"Alexander","family":"Chye","sequence":"first","affiliation":[{"name":"The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Jan","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala Bhoo","family":"Pathy","sequence":"additional","affiliation":[{"name":"Centre for Epidemiology and Evidence-Based Practice, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herdee Gloriane C","family":"Luna","sequence":"additional","affiliation":[{"name":"ACT NOW Breast Cancer Early Detection, Philippine Cancer Society, Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad B","family":"Lim","sequence":"additional","affiliation":[{"name":"Jose R Reyes Memorial Medical Center, Department of Health, Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merel","family":"Kimman","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia"},{"name":"School of Public Health, The George Institute for Global Health UK, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Peters","sequence":"additional","affiliation":[{"name":"School of Public Health, The George Institute for Global Health UK, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Monaghan","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corazon A","family":"Ngelangel","sequence":"additional","affiliation":[{"name":"University of the Philippines Manila, College of Medicine, Manila, Philippines"},{"name":"Philippine Cancer Society, Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7188-7740","authenticated-orcid":false,"given":"Blake","family":"Angell","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"2025073013354177000_10.2.e016402.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31392-7"},{"key":"2025073013354177000_10.2.e016402.2","unstructured":"Cancer Philippines 2020 country profile [World Health Organisation]. 2023. Available: https:\/\/www.who.int\/publications\/m\/item\/cancer-phl-2020"},{"key":"2025073013354177000_10.2.e016402.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-015-0433-1","article-title":"Catastrophic health expenditure and 12-month mortality associated with cancer in Southeast Asia: results from a longitudinal study in eight countries","volume":"13","author":"Kimman","year":"2015","journal-title":"BMC Med"},{"key":"2025073013354177000_10.2.e016402.4","unstructured":"World Bank Group . Urban population (% of total population) - Philippines. United Nations Population Division. World Urbanization Prospects: 2018 Revision. 2018."},{"key":"2025073013354177000_10.2.e016402.5","unstructured":"Albert J , Briones R , Rivera J . Wealth creation for expanding the middle class in the Philippines. Report no.: 2024\u201310. Quezon City; 2024."},{"key":"2025073013354177000_10.2.e016402.6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.47895\/amp.v52i2.418","article-title":"Philippine Costs in Oncology (PESO): Describing the Economic Impact of Cancer on Filipino Cancer Patients Using the ASEAN Costs in Oncology Study Dataset","volume":"52","author":"Ngelangel","year":"2018","journal-title":"Acta Med Philipp"},{"key":"2025073013354177000_10.2.e016402.7","unstructured":"PhilHealth circular no.2024-007: z benefits package for breast cancer [PhilHealth]. 2024. Available: https:\/\/www.philhealth.gov.ph\/circulars\/2024\/PC2024-0007.pdf [Accessed 24 Apr 2024]."},{"key":"2025073013354177000_10.2.e016402.8","unstructured":"Neglangel CA , Lam HY , Rivera SA , et al . Evaluation of the Philippine health insurance corporation\u2019s z benefit packages in providing financial risk protection. University of the Philippines Manila."},{"key":"2025073013354177000_10.2.e016402.9","unstructured":"To aid more PH cancer patients gov\u2019t urged to revisit programs, boost cancer funds [Inquirer News]. Available: https:\/\/newsinfo.inquirer.net\/1788619\/to-aid-more-ph-cancer-patients-govt-urged-to-revisit-programs-boost-cancer-funds#ixzz8FuNOBoja [Accessed 19 Oct 2023]."},{"key":"2025073013354177000_10.2.e016402.10","doi-asserted-by":"crossref","unstructured":"Horton S , Gauvreau CL . Cancer in Low- and Middle-Income Countries: An Economic Overview. Disease Control Priorities, (Volume 3). 3rd edn. 2015:263\u201380.Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK343620\/","DOI":"10.1596\/978-1-4648-0349-9_ch16"},{"key":"2025073013354177000_10.2.e016402.11","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmedr.2022.101936","article-title":"Breast and cervical cancer screening in the Philippines: Challenges and steps forward","volume":"29","author":"Ho","year":"2022","journal-title":"Prev Med Rep"},{"key":"2025073013354177000_10.2.e016402.12","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13841"},{"key":"2025073013354177000_10.2.e016402.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2023.01.006"},{"key":"2025073013354177000_10.2.e016402.14","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-016-0414-z"},{"key":"2025073013354177000_10.2.e016402.15","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2023.10.149","article-title":"17P Initial outcomes of the ACT Now PRIME CARE for breast cancer: Prevention of Breast canceR (screening\/ stage shifting) utilizing Integrated MobilE Clinics and pAtient Reported online Evaluations and Education","volume":"34","author":"Luna","year":"2023","journal-title":"Ann Oncol"},{"key":"2025073013354177000_10.2.e016402.16","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2025073013354177000_10.2.e016402.17","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30257-2"},{"key":"2025073013354177000_10.2.e016402.18","doi-asserted-by":"publisher","DOI":"10.21149\/spm.v56i5.7370"},{"key":"2025073013354177000_10.2.e016402.19","unstructured":"Philippines . World Health Organisation. Available: https:\/\/data.who.int\/countries\/608 [Accessed 19 Oct 2023]."},{"key":"2025073013354177000_10.2.e016402.20","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21343"},{"key":"2025073013354177000_10.2.e016402.21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm105"},{"key":"2025073013354177000_10.2.e016402.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-019-4715-8","article-title":"Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines","volume":"19","author":"Genuino","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"2025073013354177000_10.2.e016402.23","unstructured":"XE . Currency table: PHP \u2014 Philippine Peso. 2023. Available: https:\/\/www.xe.com\/currencytables\/?from=PHP&date=2023-06-30#table-section [Accessed 01 Dec 2024]."},{"key":"2025073013354177000_10.2.e016402.24","doi-asserted-by":"crossref","unstructured":"Zuniga Y , Kraft A , Uezono D , et al . Discount Rate Determination for Economic Evaluations in HTA in the Philippines. Eur J Public Health 2020;30. doi:10.1093\/eurpub\/ckaa166.581","DOI":"10.1093\/eurpub\/ckaa166.581"},{"key":"2025073013354177000_10.2.e016402.25","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-12-125","article-title":"Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer","volume":"12","author":"Soerjomataram","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"2025073013354177000_10.2.e016402.26","unstructured":"2022 Economic performance of provinces and highly urbanized cities outside the national capital region in terms of per capita GDP [Philippine Statistics Authority | Republic of the Philippines]. 2022. Available: https:\/\/www.psa.gov.ph\/content\/2022-economic-performance-provinces-and-highly-urbanized-cities-outside-national-capital [Accessed 01 Dec 2024]."},{"key":"2025073013354177000_10.2.e016402.27","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-021-00260-0"},{"key":"2025073013354177000_10.2.e016402.28","unstructured":"Ngelangel CA . Cost-effectiveness of breast exam as a cancer screening strategy in the Philippines. Philipp J Intern Med 1994;32. Available: https:\/\/www.herdin.ph\/index.php?view=research&cid=26187"},{"key":"2025073013354177000_10.2.e016402.29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174218","article-title":"Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives","volume":"14","author":"Lim","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025073013354177000_10.2.e016402.30","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn292"},{"key":"2025073013354177000_10.2.e016402.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2013.02.004"},{"key":"2025073013354177000_10.2.e016402.32","doi-asserted-by":"crossref","unstructured":"Shi J , Guan Y , Liang D , et al . Cost-effectiveness evaluation of risk-based breast cancer screening in Urban Hebei Province. Sci Rep 2023;13. doi:10.1038\/s41598-023-29985-z","DOI":"10.1038\/s41598-023-29985-z"},{"key":"2025073013354177000_10.2.e016402.33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55388","article-title":"Financial Toxicity Among Patients With Breast Cancer Worldwide: A Systematic Review and Meta-analysis","volume":"6","author":"Ehsan","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2024-016402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T20:35:55Z","timestamp":1753907755000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2024-016402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,3]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bmjgh-2024-016402"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2024-016402","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}